देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
RANITIDINE HYDROCHLORIDE
PCO Manufacturing
A02BA02
RANITIDINE HYDROCHLORIDE
150 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
H2-receptor antagonists
Authorised
1995-05-30
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER ZANTAC ® 150 MG FILM COATED TABLETS ranitidine (as hydrochloride) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Zantac is and what it is used for 2. What you need to know before you take Zantac 3. How to take Zantac Tablets 4. Possible side effects 5. How to store Zantac 6. Contents of the pack and other information 1. WHAT ZANTAC IS AND WHAT IT IS USED FOR Zantac contains a medicine called ranitidine. This belongs to a group of medicines called H 2 -receptor antagonists. It lowers the amount of acid in your stomach. FOR ADULTS (INCLUDING THE ELDERLY) Zantac is used to: treat ulcers in the stomach, or the part of the gut it empties into (the duodenum) prevent stomach ulcers when they are a side effect of some medicines treat problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of these can cause pain or discomfort sometimes known as ‘indigestion’, ‘dyspepsia’ or ‘heartburn’ treat other conditions where reduction of acid in the stomach is likely to be beneficial trea पूरा दस्तावेज़ पढ़ें
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zantac 150mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 150mg ranitidine (as hydrochloride). For full list of excipients, _see section 6.1._ 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from the Netherlands and the UK:_ White, round, biconvex tablets, engraved ‘GXEC2’ on one side plain on the other. 4 CLINICAL PARTICULARS As per PA1077/013/003 5 PHARMACOLOGICAL PROPERTIES As per PA1077/013/003 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Microcrystalline cellulose Magnesium stearate Hypromellose Titanium dioxide (E171) Triacetin 6.2 INCOMPATIBILITIES Not applicable. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 24/11/2014_ _CRN 2150740_ _page number: 1_ 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. 6.5 NATURE AND CONTENTS OF CONTAINER Blister/foil packs containing 60 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/033/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 30 May 1995 Date of last renewal: 30 May 2010 10 DATE OF REVISION OF THE TEXT November 2014 HEALTH PRODUCTS REGULATORY AUTHORITY _____________________________________________________ पूरा दस्तावेज़ पढ़ें